Skip to content
healthcare.dev

OLOPATADINE HYDROCHLORIDE

NDC 70069-491, Olopatadine Hydrochloride, solution/ drops, from Somerset Therapeutics, LLC.

Product NDC
70069-491
Status
Listed
Labeler
Somerset Therapeutics, LLC
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA215006
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70069-491 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
70069-491-01700690491011 BOTTLE, PLASTIC in 1 CARTON (70069-491-01) / 2.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 70069049101

    GET /v1/drugs/nadac/70069049101

Use it

Look up 70069-491 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70069-491 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70069-491. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.